A detailed history of Bank Of America Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Bank Of America Corp holds 174,854 shares of CORT stock, worth $6.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174,854
Previous 673,354 74.03%
Holding current value
$6.94 Million
Previous $17 Million 66.51%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $11.1 Million - $17.2 Million
-498,500 Reduced 74.03%
174,854 $5.68 Million
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $8.14 Million - $10.6 Million
385,951 Added 134.29%
673,354 $17 Million
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $4.69 Million - $6.21 Million
188,959 Added 191.95%
287,403 $9.33 Million
Q2 2023

Aug 14, 2023

SELL
$21.44 - $25.15 $282,000 - $330,797
-13,153 Reduced 11.79%
98,444 $2.19 Million
Q1 2023

May 12, 2023

BUY
$19.2 - $24.47 $244,569 - $311,698
12,738 Added 12.89%
111,597 $2.42 Million
Q4 2022

Feb 10, 2023

BUY
$19.95 - $29.96 $312,037 - $468,604
15,641 Added 18.8%
98,859 $2.01 Million
Q3 2022

Nov 14, 2022

SELL
$24.7 - $29.12 $327,275 - $385,840
-13,250 Reduced 13.74%
83,218 $2.13 Million
Q2 2022

Aug 12, 2022

SELL
$17.33 - $25.3 $131,759 - $192,355
-7,603 Reduced 7.31%
96,468 $2.29 Million
Q1 2022

May 16, 2022

SELL
$16.53 - $25.21 $1.07 Million - $1.63 Million
-64,473 Reduced 38.25%
104,071 $2.34 Million
Q4 2021

Feb 08, 2022

SELL
$17.1 - $23.34 $747,851 - $1.02 Million
-43,734 Reduced 20.6%
168,544 $3.34 Million
Q3 2021

Nov 15, 2021

BUY
$19.68 - $22.53 $889,909 - $1.02 Million
45,219 Added 27.07%
212,278 $4.18 Million
Q2 2021

Sep 13, 2021

BUY
$19.97 - $24.43 $3.34 Million - $4.08 Million
167,059 New
167,059 $3.68 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.25B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.